SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio Technology General - BTGC
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (2012)7/21/2000 3:05:20 PM
From: Jim Oravetz  Read Replies (1) of 2028
 
"Contract fees in the three and six months ended June 30, 2000 were $7.5 million and $10.0 million, respectively, significant increases over contract fees of $1.7 million and $4.6 million, respectively, in the comparable 1999 periods."

Another Q saved by rather LARGE TEVA contract fees. Only 7% increase in Oxandrin.

Annual Meeting: Sept. 5th, 2000

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News